JNJ vs IDXX
By Alex · Tickerpine
Johnson & Johnson vs IDEXX Laboratories, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | IDXX |
|---|---|---|
| Price | $285.75 | $704.23 |
| Market cap | $687.89B | $55.48B |
| P/E ratio | 43.4 | 47.5 |
| ROE | 20.02% | 68.93% |
| Profit margin | 16.20% | 25.36% |
| Revenue growth | 5.90% | 9.90% |
| Dividend yield | 1.88% | 0.00% |
| Beta | 0.20 | 1.54 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs IDXX in plain English
- JNJ is the bigger company — about 12.4× the market cap of IDXX.
- JNJ is cheaper on earnings (P/E 43.4 vs 47.5).
- IDXX earns a higher return on equity (69% vs 20%).
- IDXX is growing revenue faster (10% vs 6%).
- JNJ pays a dividend (1.88%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
IDXX return calculator
See what $1,000 in IDEXX Laboratories, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.